DTL
DFTX

Dynamic Technology Lab’s Definium Therapeutics DFTX Stock Holding History

Dynamic Technology Lab’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,880
Closed -$206K – 941
2026
Q1 		$206K Sell
10,880
-12,084
-53% -$205K 0.03% 734
2025
Q4 		$308K Buy
22,964
+12,612
+122% +$156K 0.07% 472
2025
Q3 		$122K Sell
10,352
-4,271
-29% -$39.8K 0.02% 717
2025
Q2 		$95K Buy
+14,623
New +$96.2K 0.01% 852

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dynamic Technology Lab's DFTX Position: Q2 2026 in Review

Dynamic Technology Lab sold out of Definium Therapeutics (DFTX) in Q2 2026, closing a stake of 10,880 shares — an estimated $206K sold.

Dynamic Technology Lab first reported a position in DFTX in Q2 2025 and held it in 4 quarters. The position peaked at $308K in Q4 2025. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Dynamic Technology Lab reported no remaining Definium Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Dynamic Technology Lab sold 10,880 Definium Therapeutics shares in Q2 2026, an estimated $206K.
  • Dynamic Technology Lab first reported a position in Definium Therapeutics in Q2 2025 and held it in 4 quarters.
  • Dynamic Technology Lab's Definium Therapeutics position peaked at $308K in Q4 2025.
  • 362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.